15:54 Feb 25

Alembic Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
739.90
-10.95 (-1.46%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Alembic Pharmaceuticals Ltd. Financials

Alembic Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
739.90
-10.95 (-1.46%)
15:54 Feb 25
Quality
image/svg+xml

54/100
Medium Financial Strength

Valuation
image/svg+xml

35/100
Mid Valuation

Technical

31/100
Technically Bearish

Strength

4

Weakness

8

Opportunity

1

Threats

1

11.23 %

ROE %

7.50 %

ROA %

32.00

EPS

264.10

BVPS

8.74 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
5393.13 5305.79 5652.62 6228.62 6672.08
Operating Expenses +
3835.58 4431.63 4944.24 5295.27 5663.84
Raw Material
1451.27 1489.61 1630.17 1857.92 2083.13
Increase Decrease in Cost
-193.93 -43.19 78.65 -142.84 -289.77
Other Manufacturing Expense
22.39 0 50.9 0 0
Employee Cost
1051.17 1133 1169.13 1446.29 1562.34
Miscellaneous Expenses
2036.52 2573.21 2775.57 3043.72 3130.06
Operating Profit
1557.55 874.16 708.38 933.35 1008.24
Other Income
10.02 50.46 2.74 28.31 42.55
Depreciation
183.47 286.78 275.43 272.67 278.58
Interest
16.02 17.73 50.17 56.19 78.77
Profit before tax and exceptio..
1368.08 620.11 385.52 632.8 693.44
Exceptional Items
0 0 0 0 12.87
PBT
1368.08 620.11 385.52 632.8 706.31
Provision for Taxation
253.32 104.46 12.61 16 125.17
Net Profit
1114.76 515.65 372.91 616.8 581.14
NET Profit after MI
1178.11 520.94 341.99 615.82 583.42
EPS
60.81 26.5 17.4 31.33 29.68
Operating Profit Margin (%)
28.88 16.48 12.53 14.98 15.11
Net Profit Margin (%)
21.84 9.82 6.05 9.89 8.74

Alembic Pharmaceuticals Ltd. Shareholding

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 69.70 69.70 69.70 69.70 69.60 69.60
FII 4.20 4.00 4.00 3.90 4.20 3.90
Public 16.20 16.30 16.40 16.50 16.00 16.10
Others 9.90 10.00 9.90 9.90 10.20 10.40
Shareholder Shares Holding %
Download Our App On: